Benchmark Starts Intensity Therapeutics, Inc. (INTS) at Speculative Buy (correction)

July 18, 2023 6:25 AM EDT Send to a Friend
(Updated - July 18, 2023 6:27 AM EDT)

Benchmark analyst Robert Wasserman initiates coverage on Intensity Therapeutics, Inc. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login